Population-based study reveals systemic corticosteroids may increase long COVID risk in individuals with uveitis, suggesting need for further evaluation.
This large population-based study identified key risk and protective factors for long COVID among patients with NIU. Findings suggest that systemic corticosteroid-induced immune dysregulation may increase vulnerability to long COVID in individuals with severe uveitis.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: